Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 423

1.

Acute Heart Failure and Atrial Fibrillation: Insights From the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF) Trial.

Abualnaja S, Podder M, Hernandez AF, McMurray JJ, Starling RC, O'Connor CM, Califf RM, Armstrong PW, Ezekowitz JA.

J Am Heart Assoc. 2015 Aug 24;4(8). pii: e002092. doi: 10.1161/JAHA.115.002092.

2.

Worsening heart failure during hospitalization for acute heart failure: Insights from the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF).

Kelly JP, Mentz RJ, Hasselblad V, Ezekowitz JA, Armstrong PW, Zannad F, Felker GM, Califf RM, O'Connor CM, Hernandez AF.

Am Heart J. 2015 Aug;170(2):298-305. doi: 10.1016/j.ahj.2015.04.007. Epub 2015 Apr 15.

PMID:
26299227
3.

Predictors of clinical outcomes in acute decompensated heart failure: Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure outcome models.

Khazanie P, Heizer GM, Hasselblad V, Armstrong PW, Califf RM, Ezekowitz J, Dickstein K, Levy WC, McMurray JJ, Metra M, Tang WH, Teerlink JR, Voors AA, O'Connor CM, Hernandez AF, Starling R.

Am Heart J. 2015 Aug;170(2):290-297.e1. doi: 10.1016/j.ahj.2015.04.006. Epub 2015 Apr 11.

PMID:
26299226
4.

Admission hypoxia-inducible factor 1α levels and in-hospital mortality in patients with acute decompensated heart failure.

Li G, Lu WH, Wu XW, Cheng J, Ai R, Zhou ZH, Tang ZZ.

BMC Cardiovasc Disord. 2015 Jul 30;15:79. doi: 10.1186/s12872-015-0073-6.

5.

Challenging the two concepts in determining the appropriate pre-discharge N-terminal pro a brain natriuretic peptide treatment target in acute decompensated heart failure patients: absolute or relative discharge levels?

Stienen S, Salah K, Eurlings LW, Bettencourt P, Pimenta JM, Metra M, Bayes-Genis A, Verdiani V, Bettari L, Lazzarini V, Tijssen JP, Pinto YM, Kok WE.

Eur J Heart Fail. 2015 Jul 29. doi: 10.1002/ejhf.320. [Epub ahead of print]

PMID:
26222618
6.

Volume Overload in Heart Failure: An Evidence-Based Review of Strategies for Treatment and Prevention.

Houston BA, Kalathiya RJ, Kim DA, Zakaria S.

Mayo Clin Proc. 2015 Jul 16. pii: S0025-6196(15)00351-1. doi: 10.1016/j.mayocp.2015.05.002. [Epub ahead of print] Review.

PMID:
26189443
8.

The dose-dependent effect of nesiritide on renal function in patients with acute decompensated heart failure: a systematic review and meta-analysis of randomized controlled trials.

Xiong B, Wang C, Yao Y, Huang Y, Tan J, Cao Y, Zou Y, Huang J.

PLoS One. 2015 Jun 24;10(6):e0131326. doi: 10.1371/journal.pone.0131326. eCollection 2015.

9.

Natriuretic peptides for the treatment of acute heart failure: a focus on nesiritide in recent clinical trials.

Fajardo J, Heywood JT, Patterson JH, Adams K, Chow SL.

Expert Rev Cardiovasc Ther. 2015;13(7):743-51. doi: 10.1586/14779072.2015.1051034. Epub 2015 May 31.

PMID:
26028173
10.

De novo acute heart failure and acutely decompensated chronic heart failure.

Hummel A, Empe K, Dörr M, Felix SB.

Dtsch Arztebl Int. 2015 Apr 24;112(17):298-310. doi: 10.3238/arztebl.2015.0298.

11.

Significance of low plasma levels of brain-derived neurotrophic factor in patients with heart failure.

Takashio S, Sugiyama S, Yamamuro M, Takahama H, Hayashi T, Sugano Y, Izumiya Y, Hokimoto S, Minamino N, Yasuda S, Anzai T, Ogawa H.

Am J Cardiol. 2015 Jul 15;116(2):243-9. doi: 10.1016/j.amjcard.2015.04.018. Epub 2015 Apr 18.

PMID:
25983281
12.

Role of Soluble ST2 as a Prognostic Marker in Patients with Acute Heart Failure and Renal Insufficiency.

Kim MS, Jeong TD, Han SB, Min WK, Kim JJ.

J Korean Med Sci. 2015 May;30(5):569-75. doi: 10.3346/jkms.2015.30.5.569. Epub 2015 Apr 15.

13.

Urine neutrophil gelatinase-associated lipocalin levels predict acute kidney injury in acute decompensated heart failure patients.

Soyler C, Tanriover MD, Ascioglu S, Aksu NM, Arici M.

Ren Fail. 2015 Apr 14:1-5. [Epub ahead of print]

PMID:
25869054
14.

Levosimendan and nesiritide as a combination therapy in patients with acute heart failure.

Jia Z, Guo M, Zhang LY, Zhang YQ, Liang HQ, Song Y.

Am J Med Sci. 2015 May;349(5):398-405. doi: 10.1097/MAJ.0000000000000461.

PMID:
25853935
15.

Nesiritide is beneficial or harmful to patients with decompensated acute congestive heart failure.

Ma X, Sun F, Ma J.

Int J Cardiol. 2015 May 6;187:387-8. doi: 10.1016/j.ijcard.2015.03.287. Epub 2015 Mar 20. No abstract available.

PMID:
25841132
18.

Assessment of respiratory disturbance index determined with a non-restrictive monitor and of autonomic nervous system parameters in heart failure patients: A pilot study.

Shimazu S, Hirashiki A, Kamimura Y, Nakano Y, Adachi S, Kondo T, Murohara T.

J Cardiol. 2015 Sep;66(3):218-23. doi: 10.1016/j.jjcc.2014.12.018. Epub 2015 Feb 3.

PMID:
25662622
19.

Diagnostic performance of cardiopulmonary ultrasound performed by the emergency physician in the management of acute dyspnea.

Gallard E, Redonnet JP, Bourcier JE, Deshaies D, Largeteau N, Amalric JM, Chedaddi F, Bourgeois JM, Garnier D, Geeraerts T.

Am J Emerg Med. 2015 Mar;33(3):352-8. doi: 10.1016/j.ajem.2014.12.003. Epub 2014 Dec 11.

PMID:
25572643
20.

Dynamic changes in bioelectrical impedance vector analysis and phase angle in acute decompensated heart failure.

Alves FD, Souza GC, Aliti GB, Rabelo-Silva ER, Clausell N, Biolo A.

Nutrition. 2015 Jan;31(1):84-9. doi: 10.1016/j.nut.2014.05.004. Epub 2014 May 29.

PMID:
25466653
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk